![](/img/cover-not-exists.png)
Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
Takeuchi, Tsutomu, Tanaka, Yoshiya, Tanaka, Sakae, Kawakami, Atsushi, Song, Yeong-Wook, Chen, Yi-Hsing, Rokuda, Mitsuhiro, Izutsu, Hiroyuki, Ushijima, Satoshi, Kaneko, Yuichiro, Nakashima, Yoshihiro,Volume:
22
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-020-02247-3
Date:
December, 2020
File:
PDF, 323 KB
2020